EconPapers    
Economics at your fingertips  
 

Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010–2017

Michał S. Nowak, Bożena Romanowska-Dixon, Iwona Grabska-Liberek and Michał Żurek
Additional contact information
Michał S. Nowak: Provisus Eye Clinic, 112 Redzinska str., 42-209 Czestochowa, Poland
Bożena Romanowska-Dixon: Department of Ophthalmology and Ophthalmic Oncology, Jagiellonian University Collegium Medicum, 31-501 Cracow, Poland
Iwona Grabska-Liberek: Department of Ophthalmology, Centre of Postgraduate Medical Education, 01-416 Warsaw, Poland
Michał Żurek: Department of Analyses and Strategies, Ministry of Health, 00-952 Warsaw, Poland

IJERPH, 2021, vol. 18, issue 12, 1-10

Abstract: Background : The present study aimed to investigate the incidence and characteristics of retinoblastoma in the overall population of Poland. Methods : The retrospective survey of both National Health Fund (NHF) and National Cancer Registry (NCR) databases were performed to identify all retinoblastoma cases in Poland in the years 2010–2017. Results : During 2010–2017, the mean age-standardised incidence of retinoblastoma (the unit of incidence is per 1,000,000 person-years) was 10.15 (95% CI 7.23–13.08) among children aged 0 to 4 years and 5.39 (95% CI 4.18–6.60) in those aged 0 to 9 years. During 2010–2014 (to allow 5 years of follow-up), the mean incidence of retinoblastoma by birth cohort analysis in Poland was 4.89 (95% CI 4.04–5.74) per 100,000 live births, corresponding to an incidence of 1 per 20,561 (95% CI 15,855–25,267) live births. In Poland, 14.6% of children with retinoblastoma had enucleation of the eye globe, 76.8% received different types of chemotherapy combined with focal treatment, 5.9% were treated with external beam radiotherapy, and 2.7% were treated with focal treatments only. Conclusions : The incidence of retinoblastoma and the pattern of medical management of retinoblastoma in Poland was similar to that reported in developed countries in Western Europe, Asia, and North America.

Keywords: retinoblastoma; eye surgery; chemotherapy; radiotherapy (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/12/6539/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/12/6539/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:12:p:6539-:d:576812

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-03-19
Handle: RePEc:gam:jijerp:v:18:y:2021:i:12:p:6539-:d:576812